EDIT:NASDAQ
Editas Medicine Inc
2,60 US$
arrow_downward
-0,19%(-0,0050) 1D
28 ოქტ, 09:38:35 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
2,59 US$
High
2,60 US$
Low
2,54 US$
Mkt. cap
398,54 მლნ.
Avg. vol.
2,91 მლნ.
Volume
23,33 ათ.
52-wk high
3,94 US$
52-wk low
1,66 US$
EPS
-0,74 US$
Beta
2,00
Shares outstanding
153,58 მლნ.
No. of employees
87
Open
2,59 US$
High
2,60 US$
Low
2,54 US$
Mkt. cap
398,54 მლნ.
Avg. vol.
2,91 მლნ.
Volume
23,33 ათ.
52-wk high
3,94 US$
52-wk low
1,66 US$
EPS
-0,74 US$
Beta
2,00
Shares outstanding
153,58 მლნ.
No. of employees
87
News stories
From web sources and news partners
TradingView
·
44 წუთის წინ
Firehawk Defense Tops $1.4 Billion Valuation: NYSE Content Update
24/7 Wall St.
·
2 წუთის წინ
Badly Crippled GM Moves To Nasdaq
Bloomberg.com
·
15 საათის წინ
US Stocks Drift as Caution Sets In Ahead of Fed: Markets Wrap
KSL News
·
1 საათის წინ
GM moves to Nasdaq as first legacy automaker on the exchange (Oct 27)
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc